|Targeted News Service|
As the founder and co-chair of the
Moreover, diabetes is one of our costliest diseases in economic terms. It costs our nation more than
Despite these alarming statistics, the good news is that we are making progress. Due to the Special Diabetes Program and increased investments in diabetes research, we have seen some encouraging breakthroughs and are on the threshold of a number of important new discoveries.
This is particularly true for the estimated three million Americans living with type 1 diabetes. Advances in technology, like continuous glucose monitors, are helping patients control their blood glucose levels, which is key to preventing costly and sometimes deadly diabetes complications. We are also moving closer and closer to our goal of an artificial pancreas, which would control blood glucose levels automatically and revolutionize diabetes care.
A CGM is a physician-prescribed,
As demonstrated by extensive clinical evidence, adults using a CGM have had improved overall glucose control and have reduced rates of hypoglycemia or low blood glucose levels. Professional medical societies, including the
The ironic thing is that it is only because of advances in diabetes care like the continuous glucose monitor that people with type 1 diabetes can expect to live long enough to become
I have therefore joined my colleague from
Continuous Glucose Monitors are only a few of the many breakthroughs made possible by the Special Diabetes Program. Such advances are already improving diabetes care for adults and children. They have the potential not only to improve the quality of health for individuals living with diabetes, but also to reduce long-term health expenditures from costly complications. To not provide coverage for these devices under
We are making significant advances in the battle against this disease, and to continue that momentum,
TNS 24KuanRap-140823 30FurigayJof-4836691 30FurigayJof
|Copyright: </td>||(c) 2014 Targeted News Service|